Galileo Research Facts No. 172: Can Galileo Therapy increase Muscle Function in Interstitial Lung Diseases (ILD)?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 172: Can Galileo Therapy increase Muscle Function in Interstitial Lung Diseases (ILD)?

This study investigated the effects of Galileo Therapy on muscle function (6MTW, CRT) in Interstitial Lung Diseases (ILD) (Age: 49-75). Galileo group: 30° squat, 3x3min, 26Hz, pos. 2-3, 16 weeks, 3/week, Control: identical exercises without Galileo. The Galileo group showed significant improvements in muscle function in 6MWT (+6%) and CRT (+13%) and at the same time an decrease in the inflammation parameter IL-6 (-33%)…

Continue reading

Galileo Research Facts No. 163: Can Galileo Therapy improve walking distance in kids with CP?
18 Sep
GRFS, Kids-Therapy

Galileo Research Facts No. 163: Can Galileo Therapy improve walking distance in kids with CP?

This study investigated the effects of Galileo Therapy in Cerebral Palsy (CP, GMFCS 1&2, age 5-10) (Cologne Concept: 3×3 minutes, 10 session/week, 26 weeks) on walking distance (6MWT). Galileo Therapy showed a significant increase in walking distance after 6 months (+17%) while there was no further increase in the following 6 months without Galileo but with individual standard therapy…

Continue reading

Galileo Research Facts No. 34: Can Galileo Therapy increase power in patients with acute COPD exacerbations?
15 Sep
GRFS, Therapy

Galileo Research Facts No. 34: Can Galileo Therapy increase power in patients with acute COPD exacerbations?

This study tested the effect of Galileo Therapy on muscle function and power in patients with acute COPD (exacerbations) (20Hz, pos. 2, 3*2 min., 5/week, 2-3 weeks, bent knees). Both groups received standard physiotherapy (20 min/day), the Galileo group additional Galileo Therapy (3*2 min.). The Galileo group showed significantly higher results than the reference group with an increase in the 6. min. walking test of 57%…

Continue reading